Drug Could Beat Back HIV — If People Could Get It

Cabotegravir is a promising HIV prevention medication that’s approved in countries like the United States. But in sub-Saharan Africa, access encounters a number of hurdles.

Related Keywords

Uganda ,United Kingdom ,Moroto ,Kampala ,Cannet ,Isles Of Scilly ,United States ,Makerere ,Ugandan ,Ugandans ,Abias Rwamwiri ,Clemensia Nakabiito ,Nakisanze Segawa ,Shakirah Namwanje ,Matt Haney ,Nelson Musoba ,Mitchell Warren ,Charles Brown ,Africa Annets ,Johns Hopkins University ,Service Organisations ,Makerere University ,World Health Organization ,National Drug Authority ,United Nations ,African Medicines Agency ,Uganda Network ,Preventive Care International ,European Medicines Agency ,African Union ,Saharan African ,Viiv Healthcare ,Saharan Africa ,Pharmaceutical Policy ,